Skip to main content

and
  1. Article

    Open Access

    Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants

    The new coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic, which so far has caused over 6 million deaths in 2 years, despite new vaccines and antiviral medications. Drug repurposing, an ap...

    Daniela Iaconis, Licia Bordi, Giulia Matusali, Carmine Talarico in Cell Death & Disease (2022)

  2. Article

    Open Access

    B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation

    Combined antiretroviral therapy (cART) for HIV-1 dramatically slows disease progression among HIV+ individuals. Currently, lymphoma represents the main cause of death among HIV-1-infected patients. Detection of p...

    Cinzia Giagulli, Francesca Caccuri, Simone Zorzan, Antonella Bugatti in Cancer Gene Therapy (2021)

  3. Article

    Open Access

    A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual

    Since the first outbreak of SARS-CoV-2, the clinical characteristics of the Coronavirus Disease 2019 (COVID-19) have been progressively changed. Data reporting a viral intra-host and inter-host evolution favou...

    Francesca Caccuri, Alberto Zani, Serena Messali in Journal of Translational Medicine (2020)

  4. Article

    Open Access

    Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications

    p17 matrix protein released by HIV+ cells interacts with leukocytes heparan sulfate proteoglycans (HSPGs), CXCR1 and CXCR2 exerting different cytokine-like activities that contribute to AIDS pathogenesis. Sinc...

    Antonella Bugatti, Giulia Paiardi, Chiara Urbinati, Paola Chiodelli in Scientific Reports (2019)

  5. Article

    Open Access

    Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G

    We have previously reported that human herpesvirus 6 (HHV-6) infection of endothelial cells (ECs) induces the loss of angiogenic properties, through the expression of HHV-6 U94, possibly associated to the rele...

    Roberta Rizzo, Maria D’Accolti, Daria Bortolotti, Francesca Caccuri in Scientific Reports (2018)

  6. Article

    Open Access

    Myroides odoratimimus urinary tract infection in an immunocompromised patient: an emerging multidrug-resistant micro-organism

    Myroides spp. are common environmental organisms and they can be isolated predominantly in water, soil, food and in sewage treatment plants. In the last two decades, an increasing number of infections such as uri...

    Giovanni Lorenzin, Giorgio Piccinelli in Antimicrobial Resistance & Infection Contr… (2018)

  7. Article

    Open Access

    HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness

    The introduction of cART has changed the morbidity and mortality patterns affecting HIV-infected (HIV+) individuals. The risk of breast cancer in HIV+ patients has now approached the general population risk. Howe...

    Francesca Caccuri, Francesca Giordano, Ines Barone in Infectious Agents and Cancer (2017)

  8. Article

    Open Access

    HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders

    Human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorder (HAND) remains an important neurological manifestation that adversely affects a patient’s quality of life. HIV-1 matrix protein p1...

    Yasmin Zeinolabediny, Francesca Caccuri, Laura Colombo in Scientific Reports (2017)

  9. Article

    Open Access

    A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17

    Recent data highlight the presence, in HIV-1-seropositive patients with lymphoma, of p17 variants (vp17s) endowed with B-cell clonogenicity, suggesting a role of vp17s in lymphomagenesis. We investigated the m...

    Cinzia Giagulli, Pasqualina D’Ursi, Wangxiao He, Simone Zorzan in Scientific Reports (2017)

  10. Article

    Open Access

    Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17

    The human immune deficiency virus type 1 (HIV-1) matrix protein p17 (p17), although devoid of a signal sequence, is released by infected cells and detected in blood and in different organs and tissues even in ...

    Francesca Caccuri, Maria Luisa Iaria, Federica Campilongo in Scientific Reports (2016)

  11. Article

    Correction: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

    Nat. Med.; doi:10.1038/nm.4105; corrected online 16 June 2016 In the version of this article initially published online, an affiliation for Luca Schifanella was omitted and there was an error in the descriptio...

    Monica Vaccari, Shari N Gordon, Slim Fourati, Luca Schifanella in Nature Medicine (2016)

  12. No Access

    Article

    Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

    Vaccari et al. report that SIV vaccines formulated with two different adjuvants elicit distinct immune responses and effects on SIV acquisition in rhesus macaques.

    Monica Vaccari, Shari N Gordon, Slim Fourati, Luca Schifanella in Nature Medicine (2016)

  13. Article

    Open Access

    Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study

    Arnaldo Caruso, Marialuisa Iaria, Francesca Caccuri in BMC Infectious Diseases (2014)